0 NYSE Companies - January 3, 2025Gray Media Promotes Alison Davis to General Manager of WTOK-TV in Meridian, MississippiATLANTA, Jan. 03, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) today announced the promotion of Alison Davis to […]Read More
0 NYSE Companies - January 3, 2025Gray Media Names Jacque Harms as General Manager of KKTV in Colorado Springs, ColoradoATLANTA, Jan. 03, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (NYSE: GTN) has named Jacque Harms as the next General […]Read More
1 TSX News - January 3, 2025Fairfax Financial Holdings Limited: Personnel AnnouncementsTORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) is pleased to announce […]Read More
0 TSX News - January 3, 2025Rogers Communications Notice for 4Q24 Results Teleconference January 30, 2025, at 8:00 A.M. ETTORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) today issued a notice […]Read More
0 NASDAQ Companies - January 3, 2025Xunlei Announces Change of DepositarySHENZHEN, China, Jan. 03, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company […]Read More
0 NASDAQ Companies - January 3, 2025Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025CAMBRIDGE, Mass., Jan. 03, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]Read More
0 NASDAQ Companies - January 3, 2025CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product RevenueFourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately […]Read More
0 NASDAQ Companies - January 3, 2025Balchem Corporation to Present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and […]Read More
0 NASDAQ Companies - January 3, 2025Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®Adds an additional commercial and strategic rare disease product to Eton’s portfolio Galzin is FDA-approved for the treatment of the […]Read More
0 NASDAQ Companies - January 3, 2025SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceSTAMFORD, Conn., Jan. 03, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]Read More